Company Details
- Employees
- 32
- Address
- Complex And Difficult-To-Treat Diseases.
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
Please complete the CAPTCHA to continue
Related company profiles:
Electra Therapeutics Announces $183 Million Series C GlobeNewswire
Electra Therapeutics' megaround runs counter to recent industry trend - San Francisco Business Times The Business Journals
EQT Life Sciences Co-Leads USD 183 Million Series C Financing in Electra Therapeutics Cision News
Electra Therapeutics Announces First Patients Dosed in the SURPASS Phase 2/3 Pivotal Study of ELA026 in Secondary Hemophagocytic Lymphohistiocytosis (sHLH) The Manila Times
Electra Therapeutics to Present at 43rd Annual J.P. Morgan Healthcare Conference Business Wire
Electra Therapeutics Receives FDA Breakthrough Therapy and GlobeNewswire
Electra Therapeutics Presents Positive Clinical Results From Completed Phase 1b Study of ELA026 in Secondary Hemophagocytic Lymphohistiocytosis (sHLH) in an Oral Session at ASH 2024 Yahoo Finance
Electra Therapeutics secures $183m to fund Phase II/III trial of ELA026 Clinical Trials Arena
Electra Therapeutics Receives FDA Fast Track Designation for ELA026 in Secondary Hemophagocytic Lymphohistiocytosis (sHLH) Yahoo Finance
'Some encouraging signs in the market': Electra shines with $183M fundraise for rare disease trial Fierce Biotech
Electra Therapeutics raises US$183m in Series C financing European Biotechnology Magazine
Electra Therapeutics snags $183 million to target inflammatory diseases - Bizwomen The Business Journals
Electra Therapeutics Receives FDA Orphan Drug Designation for ELA026 for the Treatment of Hemophagocytic Lymphohistiocytosis (HLH) Yahoo Finance
ShopMy's $1.5b pitch, Electra Therapeutics' raise, and FalconX's buy Axios
Series C - Electra Therapeutics Crunchbase
Electra Therapeutics Raises $183M in Series C Funding FinSMEs
Electra Therapeutics: $183 Million Series C Raised To Advance SIRP-Targeted Therapies For Immune Disorders And Cancer Pulse 2.0
ELA026 Shows Promise for Secondary HLH in Phase 1b Study HCPLive
Electra Therapeutics, Inc. announced that it has received $183 million in funding from a group of investors MarketScreener
Electra Therapeutics The Pharma Letter
Electra Therapeutics appoints new chief executive The Pharma Letter
Electra Therapeutics Announces $84 Million Series B Financing and Unveils Its Novel SIRP‑Targeted Therapies for Immunological Diseases and Cancer Business Wire
Electra, one of 2 Star biotechs, snags $84M to apply brakes to 'immune system haywire' Fierce Biotech
Star Therapeutics Starts a Family with Electra BioSpace
Electra Therapeutics Secures $183 Million Series C Funding for Immunology and Cancer Therapies Global Legal Chronicle
6 +165034XXXXX
2 +151055XXXXX
Find emails, phones & company data instantly
Your AI prospecting assistant
0 records × $0.02 per record
Secure checkout
Total price
$0.50
Enter your payment details below to complete the download. We'll email you the CSV as soon as it's ready.
Processing your payment...
Please wait while we complete your transaction
Sign in required
Create a free account or sign in to continue downloading the full results.
Sign up for a free account. No credit card required. Up to 10 free credits.
Get contact details of over 750M+ profiles across 60M companies – all with industry-leading accuracy. Sales Navigator and Recruiter users, try out our Email Finder Extension.
Find business and personal emails and mobile phone numbers with exclusive coverage across niche job titles, industries, and more for unparalleled targeting. Also available via our Contact Data API.